Carepaks Medical Supplies is categorized under Medical Apparatus and Supplies in Normal, IL and active since 1997.
Carepaks Medical Supplies was established in 1997, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Medical Apparatus and Supplies business, which does work in the B2C market, and is classified as a Medical Apparatus and Supplies, under code number 4234502 by the NAICS.
If you are seeking more information, feel free to contact Cathy C Ebo at the company’s single location by writing to 209 Susan Drive, Normal, Illinois IL 61761 or by phoning (309) 454-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carepaks Medical Supplies |
| Contact Person: | Cathy C Ebo |
| Address: | 209 Susan Drive, Normal, Illinois 61761 |
| Phone Number: | (309) 454-1000 |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Apparatus and Supplies |
| SIC Code: | 5999 |
| NAICS Code: | 4234502 |
| Share This Business: |
Carepaks Medical Supplies was started in 1997 to provide professional Medical Apparatus and Supplies under the SIC code 5999 and NAICS code 4234502. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Cathy C Ebo for inquiries that concern Carepaks Medical Supplies by calling the company number (309) 454-1000, as your correspondence is most welcome. Additionally, the physical location of the single location of Carepaks Medical Supplies can be found at the coordinates 40.51329,-88.94913 as well as the street address 209 Susan Drive in Normal, Illinois 61761.
For its online presence, you may visit Carepaks Medical Supplies’s website at and engage with its social media outlets through on Twitter and on Facebook.